
New Delhi, 25 June 2021
As per news report of NDTV, Bharat Biotech has received "full emergency use authorisation" for its Covaxin brand after the company completed documentary requirements," Food and Drug Administration chief Rolando Enrique Domingo told a news briefing.
Source - NDTV
Read More >>
If you like the story and if you wish more such stories, support our effort Make a donation.

Mon Apr 06 2026 | By Newsdesk

Mon Apr 06 2026 | By Newsdesk

Mon Apr 06 2026 | By Newsdesk

Mon Apr 06 2026 | By Newsdesk

Mon Apr 06 2026 | By Admin